Incretinization logo

Incretinization – Glenmark Pharmaceuticals

Registered App ID 6170912 Class 5 Device

Trademark information

IP India · live record
Application ID
6170912
Status
Registered
Sub status
Not Applicable
Date of application
31 October 2023
Classes
5
Type
Device
Proprietor
Glenmark Pharmaceuticals Public B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026
Attorney
Vishesh And Associates[10756]301/302, A Wing, 3 Rd Floor, Shaheen Chambers, Dawood Baug, Opp. Pearl Heritage,Andheri (West), Mumbai 400 058.
State
Maharashtra
Filing mode
e-Filing
IP office
Mumbai
Used since
—
Valid / upto
31 October 2033

Goods & services

Class 5

Class 5PHARMACEUTICAL, MEDICINAL AND AYURVEDIC PREPARATIONS AND SUBSTANCES, DIETETIC FOOD AND SUBSTANCES ADAPTED FOR MEDICAL USE, DIETARY SUPPLEMENTS FOR HUMANS, NUTRITIONAL SUPPLEMENTS, NUTRACEUTICAL PREPARATIONS FOR THERAPEUTIC OR MEDICAL PURPOSES, NUTRACEUTICALS FOR USE AS DIETARY SUPPLEMENTS

PR details

GLENMARK PHARMACEUTICALS LTD., B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026, BODY INCORPORATE, (Body Incorporate)

Mark image

Device

Uploaded documents

Sign in to open
1 TM-A(TRADE MARKS APPLICATION) 31 Oct 2023
2 Journal Copy 13 Dec 2023
3 Certificate 28 May 2024

Frequently asked questions

Incretinization was applied for on 31 October 2023.

The application was filed by Glenmark Pharmaceuticals.

Class 5.

As per IP India, the status is Registered.

The listed application ID of Incretinization is 6170912.

Trademark attorney Vishesh And Associates.